Share-based Payment Arrangement, Expense of Phathom Pharmaceuticals, Inc. from 30 Jun 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Phathom Pharmaceuticals, Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 30 Jun 2019 to 30 Sep 2025.
  • Phathom Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $9,297,000, a 65% increase year-over-year.
  • Phathom Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $29,796,000, a 29% decline year-over-year.
  • Phathom Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $24,047,000, a 47% decline from 2023.
  • Phathom Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $45,025,000, a 87% increase from 2022.
  • Phathom Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $24,133,000, a 44% increase from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Phathom Pharmaceuticals, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $29,796,000 $9,297,000 +$3,662,000 +65% 01 Jul 2025 30 Sep 2025 10-Q 30 Oct 2025 2025 Q3
Q2 2025 $26,134,000 $8,272,000 +$2,173,000 +36% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $23,961,000 $5,540,000 -$86,000 -1.5% 01 Jan 2025 31 Mar 2025 10-Q 01 May 2025 2025 Q1
Q4 2024 $24,047,000 $6,687,000 -$17,897,000 -73% 01 Oct 2024 31 Dec 2024 10-K 06 Mar 2025 2024 FY
Q3 2024 $41,944,000 $5,635,000 -$505,000 -8.2% 01 Jul 2024 30 Sep 2024 10-Q 30 Oct 2025 2025 Q3
Q2 2024 $42,449,000 $6,099,000 -$1,154,000 -16% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025 2025 Q2
Q1 2024 $43,603,000 $5,626,000 -$1,422,000 -20% 01 Jan 2024 31 Mar 2024 10-Q 01 May 2025 2025 Q1
Q4 2023 $45,025,000 $24,584,000 +$17,927,000 +269% 01 Oct 2023 31 Dec 2023 10-K 06 Mar 2025 2024 FY
Q3 2023 $27,098,000 $6,140,000 +$324,000 +5.6% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024 2024 Q3
Q2 2023 $26,774,000 $7,253,000 +$1,368,000 +23% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024 2024 Q2
Q1 2023 $25,406,000 $7,048,000 +$1,273,000 +22% 01 Jan 2023 31 Mar 2023 10-Q/A 14 Jun 2024 2024 Q1
Q4 2022 $24,133,000 $6,657,000 +$2,319,000 +53% 01 Oct 2022 31 Dec 2022 10-K/A 14 Jun 2024 2023 FY
Q3 2022 $21,814,000 $5,816,000 +$1,397,000 +32% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023 2023 Q3
Q2 2022 $20,417,000 $5,885,000 +$1,648,000 +39% 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023 2023 Q2
Q1 2022 $18,769,000 $5,775,000 +$1,957,000 +51% 01 Jan 2022 31 Mar 2022 10-Q 10 May 2023 2023 Q1
Q4 2021 $16,812,000 $4,338,000 +$1,959,000 +82% 01 Oct 2021 31 Dec 2021 10-K 28 Feb 2023 2022 FY
Q3 2021 $14,853,000 $4,419,000 +$2,349,000 +113% 01 Jul 2021 30 Sep 2021 10-Q/A 09 Nov 2022 2022 Q3
Q2 2021 $12,504,000 $4,237,000 +$3,409,000 +412% 01 Apr 2021 30 Jun 2021 10-Q 02 Aug 2022 2022 Q2
Q1 2021 $9,095,000 $3,818,000 +$3,255,000 +578% 01 Jan 2021 31 Mar 2021 10-Q 10 May 2022 2022 Q1
Q4 2020 $5,840,000 $2,379,000 01 Oct 2020 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q3 2020 $2,070,000 +$2,033,000 +5495% 01 Jul 2020 30 Sep 2020 10-Q 08 Nov 2021 2021 Q3
Q2 2020 $828,000 +$799,000 +2755% 01 Apr 2020 30 Jun 2020 10-Q 10 Aug 2021 2021 Q2
Q1 2020 $563,000 01 Jan 2020 31 Mar 2020 10-Q 11 May 2021 2021 Q1
Q3 2019 $37,000 01 Jul 2019 30 Sep 2019 10-Q 10 Nov 2020 2020 Q3
Q2 2019 $29,000 01 Apr 2019 30 Jun 2019 10-Q 06 Aug 2020 2020 Q2

Phathom Pharmaceuticals, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $24,047,000 -$20,978,000 -47% 01 Jan 2024 31 Dec 2024 10-K 06 Mar 2025 2024 FY
2023 $45,025,000 +$20,892,000 +87% 01 Jan 2023 31 Dec 2023 10-K 06 Mar 2025 2024 FY
2022 $24,133,000 +$7,321,000 +44% 01 Jan 2022 31 Dec 2022 10-K/A 14 Jun 2024 2023 FY
2021 $16,812,000 +$10,972,000 +188% 01 Jan 2021 31 Dec 2021 10-K 28 Feb 2023 2022 FY
2020 $5,840,000 +$5,434,000 +1338% 01 Jan 2020 31 Dec 2020 10-K 01 Mar 2022 2021 FY
2019 $406,000 01 Jan 2019 31 Dec 2019 10-K 30 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.